Stock Events

Intellia Therapeutics (NTLA) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.5
-1.37
-1.25
-1.12

Details

Expected EPS
-1.36619
Actual EPS
-1.12
Surprise EPS
0.25
Surprise Percent
+18.02%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.12 per share for Q2 2024.

0 Comments

Share your thoughts